Cardio Diagnostics Holdings, Inc.
NasdaqCM CDIO
Cardio Diagnostics Holdings, Inc. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2024: USD -0.00
Cardio Diagnostics Holdings, Inc. Dividend Per Share is USD -0.00 for the Trailing 12 Months (TTM) ending September 30, 2024, a 0.00% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.
-
Cardio Diagnostics Holdings, Inc. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -0.00, a 0.00% change year over year.
-
Cardio Diagnostics Holdings, Inc. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -0.00.
Key data
| Date | Dividend Per Share | Free Cash Flow Per Share | Return on Assets (ROA) | Return on Equity (ROE) |
|---|
Market news
Loading...
NasdaqCM: CDIO
| CEO | Dr. Meeshanthini V. Dogan Ph.D. |
| IPO Date | Jan. 14, 2022 |
| Location | United States |
| Headquarters | 400 N Aberdeen St |
| Employees | 7 |
| Sector | Health Care |
| Industries | |
Description
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Key trends
Past 5 years
Similar companies
Phio Pharmaceuticals Corp.
USD 3.58
-45.76%
Zura Bio Limited
USD 1.95
-2.01%
Sonnet BioTherapeutics Holdings, Inc.
USD 1.52
-3.80%
ZyVersa Therapeutics, Inc.
USD 1.49
12.03%
Immix Biopharma, Inc.
USD 2.00
-5.66%
Pyxis Oncology, Inc.
USD 1.44
-5.88%
180 Life Sciences Corp.
USD 1.56
4.70%
StockViz Staff
January 15, 2025
Any question? Send us an email